Atlas Trials

Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery

Clinical trial NCT00091078 · TERMINATED

Trial details

NCT number
NCT00091078
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastrointestinal Stromal Tumor
Start date
2005-09-01
Primary completion
2006-07-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.